Field Trip Health Ltd. CEO Joseph Del Moral on Q1 2023 Results -- Earnings Call Transcript >FTRP

From Seeking Alpha: Field Trip Health Ltd. CEO Joseph Del Moral on Q1 2023 Results -- Earnings Call Transcript

Dow JonesAug 16, 2022 11:28 ET

Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022

Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies.Field Trip Discovery renamed Reunion Neuroscience Inc. ("Reunion" or

Yahoo FinanceAug 15, 2022 17:21 ET

Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal 1Q 2023 Fincl Results, Completed Corporate Reorganization on Aug 11

Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal 1Q 2023 Fincl Results, Completed Corporate Reorganization on Aug 11

Dow JonesAug 15, 2022 17:13 ET

Field Trip Health Ltd. (FTRP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Field Trip Health Ltd. (FTRP - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2022. This widely

ZacksAug 8, 2022 09:41 ET

Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET

TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, Nasdaq: FTRP) ("Field Trip" or the "Company"), a global leader in the development and delivery of psychedelic therapies,

GlobeNewswireAug 8, 2022 08:12 ET

Field Trip Health Ltd. Gets Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange

06:16 AM EDT, 08/05/2022 (MT Newswires) -- Field Trip Health Ltd. (TSX: FTRP, Nasdaq: FTRP), a global player in the development and delivery of psychedelic therapies, announced overnight Thursday that

MT NewswiresAug 5, 2022 06:18 ET